Tirzepatide is a synthetic dual GIP/GLP-1 receptor agonist peptide intended for controlled laboratory work. It is studied in experimental systems involving GIP/GLP-1 signaling, glucose regulation, appetite, and metabolic models. Descriptions of research pathways do not establish safety, effectiveness, or suitability for human or veterinary use.
Research areas include:
• Dual GIP and GLP-1 receptor activation
• Glucose-dependent endocrine signaling
• Appetite and energy-balance pathways
• Lipid and cardiometabolic biomarker models
Research limitations and safety:
• This name is also associated with regulated medicinal products. A research material is not interchangeable with a licensed medicine, and sale or promotion may be legally restricted.
• No dosing, administration, or therapeutic-use guidance is provided.
being sold for research only.





Reviews
There are no reviews yet.